Precision Scientific announced that it has received in a round of funding led by new investor Shenzhen Salubris Pharmaceuticals Co., Ltd. on June 26, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.92 CNY | +0.31% | +10.83% | -2.27% |
Apr. 23 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
Apr. 23 | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.27% | 4.8B | |
+19.27% | 43.75B | |
+27.47% | 22.06B | |
+15.11% | 14.46B | |
+12.33% | 13.62B | |
+38.36% | 11.61B | |
-9.54% | 6.9B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+9.64% | 5.32B |
- Stock Market
- Equities
- 002294 Stock
- News Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Precision Scientific announced that it has received funding from Shenzhen Salubris Pharmaceuticals Co., Ltd.